Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6249-6256

  Pascual, David W ^a   Hone, David M ^b   Hall, Stacy ^c   Van Ginkel, Frederik W ^c   Yamamoto, Masafumi ^d   Walters, Nancy ^a   Fujihashi, Kohataro ^c   Powell, Robert J ^b   Wu, Shaoguang ^b   Vancott, John L ^c   Kiyono, Hiroshi ^c,d   Mcghee, Jerry R ^c  

^a MONTANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ESCHERICHIA COLI ENTEROTOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CYTOKINES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIMBRIAE PROTEINS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS; VACCINES, SYNTHETIC;

EID: 0032723006     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Acres, S. D., R. E. Isaacson, L. A. Babiuk, and R. A. Kapitany. 1979. Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins. Infect. Immun. 25:121-126.
2. Black, R. E., K. H. Brown, S. Becker, A. Alim, and I. Huq. 1982. Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh: II. Incidence of diarrhea and association with known pathogens. Am. J. Epidemiol. 115:315-324.
3. Black, R. E. 1986. The epidemiology of cholera and enterotoxigenic Escherichia coli diarrheal disease, p. 23-32. In J. Holmgren, A. Lindberg, and R. Molby (ed.), Development of Vaccines and Drugs Against Diarrhea. Studentlitteratur, Stockholm, Sweden.
4. Curtiss, R., S. M. Kelly, P. A. Gulig, and K. Nakayama. 1989. Selective delivery of antigens by recombinant bacteria. Curr. Top. Microbiol. Immunol. 146:34-49.
5. Curtiss, R., S. M. Kelly, and J. O. Hassan. 1993. Live oral avirulent Salmonella vaccines. Vet. Microbiol. 37:397-405.
6. Edelman, R., R. G. Russell, G. Losonsky, B. D. Tall, C. O. Tacket, M. M. Levine, and D. H. Lewis. 1993. Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide). Vaccine 11:155-158.
7. Evans, D. G., D. Y. Graham, D. J. Jr., Evans, and A. Opekun. 1984. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Gastroenterology 87:934-940.
8. Evans, D. J., Jr., and D. G. Evans. 1990. Colonization factor antigens of human pathogens. Curr. Top. Microbiol. Immunol. 151:129-145.
9. Ferlin, W. G., T. von der Weid, F. Cottrez, D. A. Ferrick, R. L. Coffman, and M. C. Howard. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol. 28:525-531.
10. Fouls, T. R., R. G. Tuskan, S. Chada, D. M. Hone, and G. K. Lewis. 1995. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine 13:1697-1705.
11. Girón, J. A., J.-G. Xu, C. R. González, D. Hone, J. B. Kaper, and M. M. Levine. 1995. Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by ΔaroC, ΔaraD Salmonella typhi vaccine strain CVD 908. Vaccine 13:939-946.
12. Hall, R., D. R. Maneval, Jr., J. H. Collins, J. L. Theibert, and M. M. Levine. 1989. Purification and analysis of colonization factor antigen 1, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli. J. Bacteriol. 171:6372-6374.
13. + TCR-αβ cells and IFN-γ in bacterial clearance independent of intracellular location. J. Immunol. 156:3321-3326.
14. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA 92:2904-2908.
15. Hone, D. M., C. O. Tacket, A. H. Harris, B. Kay, G. Losonsky, and M. M. Levine. 1992. Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J. Clin. Investig. 90:412-420.
16. Jackson, R. J., K. Fujihashi, J. Xu-Amano, H. Kiyono, and J. R. McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272-4279.
17. Levine, M., J. G. Morris, G. Losonsky, E. C. Boedeker, and B. Rowe. 1986. Fimbriae (pili) adhesins as vaccine, p. 143-145. In D. L. Lark, S. Normark, B.-E. Uhlin, and H. Wolf-Watz (ed.), Protein-carbohydrate interactions in biological systems: molecular biology of microbial pathogenicity. Academic Press, London, England.
18. Levine, M. M., J. A. Girón, and F. R. Noriega. 1994. Fimbrial vaccines, p. 255-270. In P. Klemm (ed.), Fimbriae: adhesions, biogenics, genetics, and vaccines. CRC Press, Boca Raton, Fla.
19. Lu, W., D.-S. Han, J. Yuan, and J.-M. Andrieu. 1994. Multi-target PCR analysis by capillary electrophoresis and laser-induced fluorescence. Nature 368:269-271.
20. McGhee, J. R., and H. Kiyono. 1993. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 2:55-73.
21. - Salmonella vaccines. Microb. Pathog. 13:477-491.
22. Nagy, B. 1980. Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibacillosis. Infect. Immun. 27:21-24.
23. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64:1516-1525.
24. Pascual, D. W., J. R. McGhee, H. Kiyono, and K. L. Bost. 1991. Neuroimmune modulation of lymphocyte function: I. Substance P enhances immunoglobulin synthesis in LPS activated murine splenic B cell cultures. Int. Immunol. 3:1223-1229.
25. Pascual, D. W., H. Kiyono, and J. R. McGhee. 1996. Mucosal immunity: molecular and cellular aspects of immune protection to enteric infections, p. 15-35. In L. J. Paradise et al., (ed.), Enteric infections and immunity. Plenum Press, New York, N.Y.
26. Ramarathinam, L., D. W. Niesel, and G. R. Kumpel. 1993. Salmonella typhimurium induces IFN-γ production in murine splenocytes: role of natural killer cells and macrophages. J. Immunol. 150:3973-3981.
27. Reid, R. H., E. C. Boedeker, C. E. McQueen, D. Davis, L.-Y. Tseng, J. Kodak, K. Sau, C. L. Wilhelmesen, R. Nellore, P. Dalal, and H. R. Bhagat. 1993. Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli. Vaccine 11:159-167.
28. Roberts, M., S. N. Chatfield, and G. Dougan. 1994. Salmonella as carriers of heterologous antigens, p. 27-58. In D. T. O'Hagen (ed.), Novel delivery systems for oral vaccines. CRC Press, Boca Raton, Fla.
29. Schmidt, M., E. P. Kelly, L. Y. Tseng, and E. C. Boedeker. 1985. Towards an oral E. coli pilus vaccine for travelers diarrhea: susceptibility to proteolytic digestion. Gastroenterology 88:A1575-A1582.
30. Schodel, F., D. R. Milich, and H. Will. 1990. Hepatitis B virus nucleocapsid/ pres-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J. Immunol. 145:4317-4321.
31. Srinivasan, K., J. E. Girard, P. Williams, R. K. Roby, V. W. Weedn, S. Morris, M. C. Kline, and D. J. Reeder. 1993. Electrophoretic separations of polymerase chain reaction-amplified DNA fragments in DNA typing using a capillary electrophoresis-laser induced fluorescence system. J. Chromatogr. 652:83-91.
32. VanCott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella, J. Immunol. 156:1504-1514.
33. VanCott, J. L., S. N. Chatfield, M. Roberts, D. M. Hone, E. Hohmann, D. W. Pascual, M. Yamamoto, S. Yamamoto, H. Kiyono, and J. R. McGhee. 1998. Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 4:1247-1252.
34. van Ginkel, F. W., J. R. McGhee, C. G. Liu, J. W. Simecka, M. Yamamoto, R. A. Frizzell, E. J. Sorscher, H. Kiyono, and D. W. Pascual. 1997. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J. Immunol. 159:685-693.
35. Wu, S., D. W. Pascual, J. L. VanCott, J. R. McGhee, D. R. Maneval, Jr., M. M. Levine, and D. M. Hone. 1995. Immune response to Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli (ETEC) in the absence of the CFA/I positive regulator cfaR. Infect. Immun. 63:4933-4938.
36. Wu, S., D. W. Pascual, G. K. Lewis, and D. M. Hone. 1997. Induction of mucosal and systemic responses against human immunodeficiency virus type-1 gp120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Res. Hum. Retroviruses 13:1187-1194.
37. Xu-Amano, J., W. K. Aicher, T. Taguchi, H. Kiyono, and J. R. McGhee. 1992. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Intern. Immunol. 4:433-445.
38. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309-1320.
39. Yamamoto, M., D. E. Briles, S. Yamamoto, M. Ohmura, H. Kiyono, and J. R. McGhee. 1998. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A. J. Immunol. 161:4115-4121.
40. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, K. Fujihashi, F. W. van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267-5272.
41. -) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145:2281-2285.